Regen BioPharma Inc (RGBP)

[Goldstrike]

This is true. Big biotech struggles to find even one profitable drug to bring to market before their prior drug discoveries go generic. Witness Lilly's Cymbalta. Most people say it's worthless. Lilly was able to bring it to market to keep the money pipeline intact in order to continue R & D on drugs that might pan out.
This is big money Pharma struggling. How can Koots conceivably outdo these established behemoths?
Best of luck to everyone, but if you do make a little money on this stock, run for the exit and never look back!